22 research outputs found
POI6 WOMEN TREATED WITH MONTHLY IBANDRONATE DEMONSTRATE IMPROVED PERSISTENCE VERSUS WEEKLY BISPHOSPHONATES
Get PDFTeriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis
Get PDF
POI6 WOMEN TREATED WITH MONTHLY IBANDRONATE DEMONSTRATE IMPROVED PERSISTENCE VERSUS WEEKLY BISPHOSPHONATES
No full text
Potential cost-effectiveness for using patient decision aids to guide osteoporosis treatment
No full textAnálisis del impacto presupuestario para el Sistema Nacional de Salud del tratamiento de la osteoporosis con calcio y vitamina D3, en relación con el cumplimiento terapéutico
No full textDenosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonate
No full textAssessing bone mineral changes in response to vitamin D supplementation using natural variability in stable isotopes of Calcium in Urine
No full text
